Of course its not only Sphere in the dog house, this year has been awful for Small Caps (-5%) and ALL AIM (-19%) with "you know who"(-21%) bringing up the rear.We all know the recent run of poor figs for Sphere, 50% down on 2013, 20% down over 2014 boy do we need this to change! I am in no doubt it will and for the better (excuse me for talking my own book) for if it doesnt?.......well too horrible to contemplate. We cannot go through another year of complete indifference by the market can we!!!!!?
Incidentally back to last years results day the volumes were 270.000 traded and over the week 348.000.Makes one wonder why investors interest fizzled out? I guess we'll never really know perhaps apathy? Underpinned by these +/- figs.To date UP days 21.DOWN days 29.U/C days 193. Says it all! With so few trading days left those figs wont change much but when on 76% of trading days the share price remains static you can see how tough the going is.My hopes as are all Sphereholders that 2014 one foot forward two feet back will soon be forgotten.If 2015 is anything like '14 we'll be in serious trouble. Wont happen I feel sure.An upbeat statement from Sphere come results time (Hospital take-ups) going very well (Proxima) exceeding expectations etc, etc......anything less then,.....Ouch!
Most investors will be shutting down for the Xmas and New Year festivities as 2014 ends on a depressing note for Spereholders! Volumes as per norm were miniscule, 1 trade all day if we cont at this rate a quote wont be needed, well you get my drift? Early Jan sees Sphere at the JPM healthcare conference and then into Europe with further roadshows. No doubt in my mind Sphere are pursuing the right strategy the last thing we want is for the co to go hell for leather, sales at any cost just to get revenues, no we have the right product at the right time and demand will become apparent when hospitals realise how much more efficient and economic Proxima is to their bottom line not to mention a better outcome for patients! Im sure a sales strategy has been mapped out and realistic targets set for next year which if achieved will transform Sphere from a maybe co to a co on the road to inevitable success.
Pencil in late Feb 2015 for the f/yr results (2014 on 27/2) when the sp was 27p (+1.5p) on Dr Renckens appointment as CEO.
When the price of a medical product or device runs into the tens of thousands of pounds, most clinicians and providers require "published" evidence of a health benefit.The Proxima data from QE2 I should think has been prepared and will go a long way to underpin Proxima claims in the healthcare environment. If hospitals have to wait for the published data on Proxima this may slow down sales going into H1 2015? But thereafter as more hospitals see Proxima in action imo sales will steadily increase bolstered by our entry into Belgium and Germany.Exciting times ahead for Sphere, though the next fund raise looms ever closer.
14 Dec '14
Last month Sphere Medical (77.75p) became the second Cambridge co to debut on AIM this year with a mrkt cap of (£34m).It has used micro-electronic technology to miniaturise a (£19k) benchtop blood gas analyser into a disposable bio sensor that provides near real time results etc,............. Broker Peel Hunt expects the co to break even in 2014. This was taken from the Guardian newspaper's share tips for 2012. If were lucky enough to be tipped for 2015 lets hope it has the reverse effect from the 2012 selection.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.